Long-term Safety of Rituximab (Mabthera) in Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA): Rituximab Surveillance Study in VASculitis (RIVAS)

被引:0
|
作者
Uchida, Lisa [1 ]
Jones, Rachel [2 ]
Smith, Rona [1 ]
Loechel, Claudia [3 ]
King, Maria [3 ]
Nodale, Marianna [4 ]
Bond, Simon [4 ]
Luqmani, Raashid [5 ]
Gray, David [5 ]
Barrett, Joe [5 ]
Jayne, David [6 ]
机构
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Addenbrookes Hosp, Vasculitis & Lupus Clin, Cambridge, England
[3] Cambridge Univ Hosp NHS Fdn Trust, Vasculitis & Lupus Clin, Cambridge, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Clin Trials Unit, Cambridge, England
[5] Univ Oxford, Nuffield Dept Orthoped, Rheumatol & Musculoskeletal Sci, Oxford, England
[6] Univ Cambridge, Cambridge, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0679
引用
收藏
页码:1354 / 1356
页数:3
相关论文
共 50 条
  • [1] LONG-TERM SURVEILLANCE STUDY OF RITUXIMAB (MABTHERA)-TREATED PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA): RITUXIMAB SURVEILLANCE STUDY IN VASCULITIS (RIVAS)
    Uchida, L.
    Loechel, C.
    Nodale, M.
    Bond, S.
    Jayne, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 339 - 339
  • [2] Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
    Uchida, Lisa
    Jones, Rachel B.
    Smith, Rona M.
    Nodale, Marianna
    Bond, Simon
    Loechel, Claudia
    King, Maria
    Luqmani, Raashid
    Gray, David
    Barrett, Joe
    Jayne, David R. W.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (03)
  • [3] Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
    Merkel, Peter A.
    Niles, John L.
    Mertz, Lester E.
    Lehane, Patricia B.
    Pordeli, Pooneh
    Erblang, Felix
    ARTHRITIS CARE & RESEARCH, 2021, 73 (09) : 1372 - 1378
  • [4] SAFETY FOLLOWING INITIATION OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA): INTERIM ANALYSIS OF THE RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY (RAVER)
    Niles, John
    Allen, Nancy B.
    Block, Joel A.
    Koening, Curry L.
    Langford, Carol A.
    Abril, Andy
    Lee, Augustine S.
    Merkel, Peter A.
    Mertz, Lester E.
    Monach, Paul A.
    Moreland, Larry W.
    Nachman, Patrick H.
    Peikert, Tobias
    Spiera, Robert F.
    Wallace, Daniel
    Erblang, Felix
    Cascino, Matthew D.
    Duncombe, Paul
    Malik, Vineeta
    Brunetta, Paul
    RHEUMATOLOGY, 2017, 56 : 158 - 158
  • [5] SAFETY FOLLOWING INITIATION OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA): INTERIM ANALYSIS OF THE RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY (RAVER)
    Niles, J.
    Allen, N.
    Block, J. A.
    Koening, C. L.
    Langford, C. A.
    Abril, A.
    Lee, A. S.
    Merkel, P. A.
    Mertz, L. E.
    Monach, P. A.
    Moreland, L. W.
    Nachman, P. H.
    Peikert, T.
    Spiera, R. F.
    Wallace, D.
    Erblang, F.
    Cascino, M. D.
    Duncombe, P.
    Malik, V.
    Brunetta, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 318 - 318
  • [6] MABTHERA® (RITUXIMAB) FOR THE TREATMENT OF SEVERE GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA) - A COST-UTILITY MODEL FOR THE UNITED KINGDOM
    Harland, D.
    Naisbett-Groet, B.
    Chang, S.
    Sungher, D. K.
    Sawyer, L.
    Diamantopoulos, A.
    VALUE IN HEALTH, 2014, 17 (07) : A382 - A382
  • [7] Long-Term Safety of Rituximab in Granulomatosis with Polyangiitis or Microscopic Polyangiitis: Results of the Four-Year Study of Rituximab in ANCA-Associated Vasculitis Registry
    Niles, John L.
    Merkel, Peter A.
    Mertz, Lester
    Lehane, Patricia B.
    Pordeli, Pooneh
    Erblang, Felix
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] LONG-TERM SAFETY OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS OR MICROSCOPIC POLYANGIITIS: RESULTS OF THE FOUR-YEAR RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY
    Niles, John
    Merkel, Peter
    Mertz, Lester
    Lehane, Patricia
    Pordeli, Pooneh
    Erblang, Felix
    RHEUMATOLOGY, 2019, 58 : 146 - 146
  • [9] PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)
    Brogan, P.
    Cleary, G.
    Kasapcopur, O.
    Rangaraj, S.
    Yeung, R.
    Brunetta, P.
    Cooper, J.
    Pordeli, P.
    Lehane, P. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 212 - 212
  • [10] Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA)
    Gawryluk, Dariusz
    Fijolek, Justyna
    Wiatr, Elzbieta
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52